Found: 6
Select item for more details and to access through your institution.
Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.
- Published in:
- Scientific Reports, 2017, p. 42980, doi. 10.1038/srep42980
- By:
- Publication type:
- Article
HOPX functions as a tumour suppressor in head and neck cancer.
- Published in:
- Scientific Reports, 2016, p. 38758, doi. 10.1038/srep38758
- By:
- Publication type:
- Article
Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0130464
- By:
- Publication type:
- Article
DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.763086
- By:
- Publication type:
- Article
An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/3857853
- By:
- Publication type:
- Article
The origins, roles and therapies of cancer associated fibroblast in liver cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1151373
- By:
- Publication type:
- Article